Dark

Check out our API

ENZN
VISKASE HOLDINGS INC
stock OTC

Inactive

Jul 22, 2026

4.35USD-0.838%(-0.04)2,271

Pre-market

0.00USD-100.000%(-4.39)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 4, 2021

08:55AM EST Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to GlobeNewswire Inc

Oct 21, 2020

04:15PM EDT Enzon Pharmaceuticals, Inc.(the Company or Enzon) (OTC:ENZN) announced the results of its rights offering following the expiration of the subscription period on October 9, 2020 at 5:00 p.m. New York City Time. GlobeNewswire Inc

Sep 15, 2020

04:15PM EDT Enzon Pharmaceuticals Announces Key Dates for Rights Offering GlobeNewswire Inc

Sep 2, 2020

04:15PM EDT Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual GlobeNewswire Inc

Aug 21, 2020

04:30PM EDT Enzon Pharmaceuticals Anticipated Rights Offering to Existing GlobeNewswire Inc

Aug 14, 2020

05:00PM EDT Enzon Pharmaceuticals, Inc. (the Company or Enzon) (OTC:ENZN) today announced that its Board of Directors (the Board) adopted a tax benefits preservation plan (the Section 382 Rights Plan) designed to protect the availability of Enzons net operating loss carryforwards (NOLs) under the Internal Revenue Code (the Code). GlobeNewswire Inc

Share